|
|
Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne Cardiomyopathy |
| 1 K08 HL155852-01 |
|
NHLBI |
2021 |
|
|
Functional Characterization of Children with Chronic Venous Thromboembolic Disease |
| 1 R01 HL153963-01A1 |
|
NHLBI |
2021 |
|
|
Blood Pressure and Outcomes in Contemporary Left Ventricular Assist Device Recipients |
| 1 R01 HL155201-01 |
|
NHLBI |
2021 |
|
|
Risk prediction and longitudinal assessment of cardiotoxicity and functional capacity trajectory in NSCLC patients |
| 1 R01 HL157273-01 |
|
NHLBI |
2021 |
|
|
Omniphobic Coating of Extracorporeal Life Support Systems for Improved Thromboresistance |
| 1 R43 HL156321-01A1 |
|
NHLBI |
2021 |
|
|
Development of a CO2-bicarbonate combined membrane capture system for accessible treatment of acute respiratory failure. |
| 1 R43 HL158345-01 |
CHANG, BRIAN YALE |
NHLBI |
2021 |
|
|
Development of a Minimally Invasive Single Cannulation, Compact Single Port Pulsatile Ventricular Assist Device (sppVAD) for Total LV Support |
| 1 R43 HL158430-01 |
|
NHLBI |
2021 |
|
|
Urgent and unmet need for a long-term solution for increasing pediatric heart-failure population: BiVACOR Rotary Total Artificial Heart |
| 1 R44 HL156370-01 |
|
NHLBI |
2021 |
|
|
Peripheral Artery Disease: Long-term Survival & Outcomes Study (PEARLS) |
| 1 R56 HL158803-01 |
|
NHLBI |
2021 |
|
|
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia |
| 1 R61 HL151952-01A1 |
|
NHLBI |
2021 |
